(AP) — Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for ...
Pfizer and BioNTech, makers of the Food and Drug Administration-approved COVID-19 vaccine Comirnaty, shared today that their vaccine is effective among children ages 5 to 11 and that they will seek ...
New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants ...
COVID-19 vaccines for children between the ages of 5 and 11 could get the green light from the US Food and Drug Administration sometime this fall, Dr. Anthony Fauci said. "If you look at the studies ...
Oct 13 (Reuters) - Pfizer Inc (PFE.N), opens new tab will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works in a wider age group. While ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
Add Yahoo as a preferred source to see more of our stories on Google. The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but led to ...
New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results